MedTrace Logo

Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

NCT04185441 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 295

Last updated 2025-12-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Tanzânia association in adults with erectile dysfunction associated with Benign Prostatic Hyperplasia.

Conditions

Interventions

DRUG

Tanzânia association

Tanzânia association capsule

DRUG

Omnic Ocas

Tamsulosin 0,4 mg

OTHER

Omnic Ocas placebo

Tamsulosin placebo

OTHER

Tanzânia association placebo

EMS association placebo

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-14
Primary Completion
2023-10-10
Completion
2024-07-05

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185441 on ClinicalTrials.gov